FibroBiologics Inc. Commo... (FBLG)
NASDAQ: FBLG
· Real-Time Price · USD
0.57
-0.02 (-3.06%)
At close: Aug 15, 2025, 3:59 PM
0.57
-1.21%
After-hours: Aug 15, 2025, 05:55 PM EDT
FibroBiologics Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | -4.66M | -4.97M | -3.1M | -500K | 898K | -8.46M | -9.72M | -2.19M | -2.16M | -2.42M | -1.52M | -1.56M | -1.02K | -1.02K |
Depreciation & Amortization | 206K | 161K | 153K | 143K | 140K | 137K | 130K | 112K | 99K | 96K | 229K | n/a | 59.00 | 59.00 |
Stock-Based Compensation | 729K | 551K | 544K | 571K | 578K | 525K | 432K | 437K | 448K | 448K | 32K | 65K | 84.00 | 84.00 |
Other Working Capital | n/a | -525K | -1.8M | -15K | 69K | 560K | 318K | 282K | -48K | 17K | -175K | -6K | 18.50 | 18.50 |
Other Non-Cash Items | -261K | n/a | -392K | -2.78M | -4.03M | 4.04M | 7.93M | n/a | 60K | 1.01M | 265K | 136K | 93.00 | 93.00 |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -1.55M | -279K | -44K | 463K | 419K | 318K | 504K | -71K | -258K | -175K | -6K | 18.50 | 18.50 |
Operating Cash Flow | -3.98M | -5.28M | -3.07M | -2.61M | -1.95M | -4.28M | -1.6M | -1.14M | -1.63M | -2.04M | -1.17M | -1.37M | -763 | -763 |
Capital Expenditures | -213K | -43K | -99K | -11K | -66K | -8K | -2K | -413K | -24K | -56K | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -213K | -43K | -99K | -11K | -66K | -8K | -2K | -413K | -24K | -56K | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | 9.29M | -172K | n/a | 459K | n/a | n/a | 300K | n/a | n/a | -300K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.38M | n/a | n/a | n/a | -172K | n/a | n/a | n/a | -2.01M | 9.68M | n/a | n/a | 2.04K | 2.04K |
Financial Cash Flow | 4.38M | n/a | 9.33M | 4.47M | -172K | 3.28M | n/a | 940K | -1.71M | 14.57M | 2.15M | -300K | 2.04K | 2.04K |
Net Cash Flow | 178K | -5.32M | 6.16M | 1.85M | -2.19M | -1M | -1.6M | -612K | -3.36M | 12.47M | 977K | -1.67M | 2.96K | n/a |
Free Cash Flow | -4.2M | -5.32M | -3.17M | -2.62M | -2.01M | -4.28M | -1.6M | -1.55M | -1.65M | -2.09M | -1.17M | -1.37M | -763 | -763 |